| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1315628 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MBNL2 mRNA | CTD | PMID:22079256 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1591755 | 6480464 | Ethinyl Estradiol results in increased expression of MBNL2 mRNA | CTD | PMID:17108234 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1315628 | 6480464 | Ethinyl Estradiol results in decreased expression of MBNL2 mRNA | CTD | PMID:18936297 |
| 17alpha-ethynylestradiol | increases expression | ISO | | 6480464 | Ethinyl Estradiol results in increased expression of MBNL2 mRNA | CTD | PMID:17108234 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBNL2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBNL2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MBNL2 mRNA | CTD | PMID:21570461 |
| 2-methylcholine | affects expression | ISO | RGD:1315628 | 6480464 | beta-methylcholine affects the expression of MBNL2 mRNA | CTD | PMID:21179406 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of MBNL2 mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1315628 | 6480464 | Tretinoin results in increased expression of MBNL2 mRNA | CTD | PMID:21934132 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1591755 | 6480464 | Tretinoin results in increased expression of MBNL2 mRNA | CTD | PMID:20488242 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of MBNL2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MBNL2 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1315628 | 6480464 | Benzo(a)pyrene results in decreased expression of MBNL2 mRNA | CTD | PMID:20064835 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MBNL2 mRNA | CTD | PMID:21932408 |
| ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of MBNL2 mRNA | CTD | PMID:18353800 |
| copper(2+) sulfate | increases expression | ISO | RGD:1315628 | 6480464 | Copper Sulfate results in increased expression of MBNL2 mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | ISO | RGD:1315628 | 6480464 | Cyclosporine results in increased expression of MBNL2 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:1315628 | 6480464 | Cyclosporine results in increased expression of MBNL2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of MBNL2 mRNA | CTD | PMID:19770486 |
| diarsenic trioxide | increases expression | ISO | RGD:1315628 | 6480464 | arsenic trioxide results in increased expression of MBNL2 mRNA | CTD | PMID:22521957 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of MBNL2 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:1591755 | 6480464 | Dibutyl Phthalate results in increased expression of MBNL2 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | | 6480464 | Dibutyl Phthalate results in increased expression of MBNL2 mRNA | CTD | PMID:21266533 |
| dioxygen | increases expression | ISO | RGD:1315628 | 6480464 | Oxygen deficiency results in increased expression of MBNL2 mRNA | CTD | PMID:20042640 |
| nickel dichloride | increases expression | ISO | RGD:1315628 | 6480464 | nickel chloride results in increased expression of MBNL2 mRNA | CTD | PMID:17312168 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of MBNL2 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:1315628 | 6480464 | Acetaminophen results in decreased expression of MBNL2 mRNA | CTD | PMID:21420995 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of MBNL2 mRNA | CTD | PMID:21278054 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of MBNL2 mRNA | CTD | PMID:21278054 PMID:22334560 |
| quercetin | decreases expression | ISO | RGD:1315628 | 6480464 | Quercetin results in decreased expression of MBNL2 mRNA | CTD | PMID:21632981 |
| raloxifene | multiple interactions | ISO | RGD:1315628 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in decreased expression of MBNL2 mRNA | CTD | PMID:19059307 |
| sirolimus | multiple interactions | ISO | RGD:1315628 | 6480464 | Sirolimus inhibits the reaction [TP73 protein results in increased expression of MBNL2 mRNA] | CTD | PMID:21245298 |
| tamoxifen | multiple interactions | ISO | RGD:1315628 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of MBNL2 mRNA | CTD | PMID:19059307 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1315628 | 6480464 | tert-Butylhydroperoxide results in decreased expression of MBNL2 mRNA | CTD | PMID:15336504 |
| testosterone enanthate | affects expression | ISO | RGD:1315628 | 6480464 | testosterone enanthate affects the expression of MBNL2 mRNA | CTD | PMID:17440010 |
| zinc sulfate | decreases expression | ISO | RGD:1315628 | 6480464 | Zinc Sulfate results in decreased expression of MBNL2 mRNA | CTD | PMID:12756304 |